Understanding Morphine Equivalent Dose (Med) and Why It Matter in Claims Management

By: Christina Klemm, Pharm.D., BCACP, Clinical Operations, Enlyte

Morphine Equivalent Dose (MED) is a standardized way to estimate a person’s total opioid exposure over a 24-hour period. Because different opioid medications have varying potencies, a common measurement helps you compare “apples to apples.” 

For example, 5 mg of oxycodone is not equal to 5 mg of morphine in terms of pain relief or risk potential. Converting all opioids to a total daily MED helps clarify the overall daily dose and supports more consistent claim decisions. 

Why MED Matters in Claims Management 

For workers’ compensation claims, MED can help support safer, more effective care by improving visibility into: 

1. Risk Assessment: Higher MED levels are associated with increased risks of adverse effects, including respiratory depression, overdose and dependency.
2. Treatment Monitoring: MED helps track whether an individual’s pain management plan follows current safety guidelines.
3. Guideline Adherence: Both the Centers for Disease Control and Prevention (CDC) and Official Disability Guidelines (ODG) recommend keeping MED to the lowest effective dose, preferably below 50 MED and avoiding escalation above 90 MED.
4. Return-to-Work Planning: Lower MED levels generally support better functional outcomes and safer return-to-work transitions.

Understanding the Risks of High MED 

A key safety concern with opioids is respiratory depression (slowed or ineffective breathing). Risk exists at any dose, and it generally increases as total daily opioid exposure rises. 

Studies have found that higher daily MED (including levels above 90 MED) can be associated with: 

• Higher risk of overdose
• Increased likelihood of developing dependency
• Greater potential for adverse side effects that may delay recovery
• Higher rates of complications with other medications

Using MED in Claim Review

When reviewing claims involving opioid medications, consider:

• Is the current MED within recommended guidelines?
• Has there been a pattern of increasing MED over time?
• Are there opportunities to support tapering to lower MED levels?
• Could alternative pain management approaches reduce reliance on opioids?

By understanding and monitoring MED, claims professionals can better support treatment plans that promote recovery while reducing avoidable risk related to long-term opioid therapy. The goal is not simply to reduce MED numbers, but to help ensure pain management supports safety, function and appropriate recovery outcomes. 

About the Author

Christina graduated with her Doctor of Pharmacy degree from the University of Arizona in 2010 and became board certified in ambulatory care in 2015. She has 7 years’ experience in workers compensation focusing on clinical programs and formulary management. Prior experience includes inpatient psychiatric rehabilitation and community-based health clinics.

Christina is also a regular contributor to the Ask the Pharmacist Series where this article originally appeared.

www.enlyte.com/ask-the-pharmacist